Senti Biosciences Holdings, Inc. filed a Form D with the Securities and Exchange Commission on 2026-06-04.
Senti Biosciences Holdings, Inc. filed a Form D notice of an exempt securities offering with the SEC on June 4, 2026. Senti Biosciences Holdings, Inc. trades on Nasdaq as SNTI; it was formerly Senti Biosciences, Inc. The filing reports $10M sold. Its industry group is Biotechnology (SEC Form D, June 4, 2026).
In its own words: “Outsmarting Complex Diseases With More Intelligent Medicines.” (sentibio.com, checked November 2, 2026)
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Senti Biosciences Holdings, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-06-04 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Senti Biosciences Holdings, Inc.
Free to see. No signup.
More on the people and the money behind Senti Biosciences Holdings, Inc., from the filings we hold.
Biotechnology raises by companies based in California, filed in June 2026, largest first.
Get an email when Senti Biosciences Holdings, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Senti Biosciences Holdings, Inc. raises, hires or launches. No email unless you switch it on.
Watch Senti Biosciences Holdings, Inc. →Get the full cited report on Senti Biosciences Holdings, Inc.
What the filing shows about Senti Biosciences Holdings, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Senti Biosciences Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Senti Biosciences Holdings, Inc.'s address as 2 Corporate Drive, First Floor, South San Francisco, CA 94080.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Senti Biosciences Holdings, Inc. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Senti Biosciences Holdings, Inc. See pricing
Senti Biosciences Holdings, Inc. is a registered filer with the SEC (CIK 1854270) and has filed since 2024-12-19. 2 filings are on record, the latest on 2026-06-04.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Senti Biosciences Holdings, Inc.'s Form D of 2026-06-04 names Timothy Lu, Edward Mathers, Frances Schulz and 7 more as its officers, directors or promoters.
Its new offerings report $47.60M sold across 2 offerings, as its own filings state.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 769 filings in Biotechnology, totalled by week. The dot is this raise, $10M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Checked away from the filing. What is below does not come from the record on sec.gov.
The Investor Relations website contains information about Senti Biosciences, Inc.'s business for stockholders, potential investors, and financial analysts.
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
On the filing as: Executive Officer, Director.
Timothy Lu is named as Chief Executive Officer of each Issuer and Director of Senti Biosciences Holdings, Inc. on the Form D that Senti Biosciences Holdings, Inc. filed with the SEC on 4 June 2026, one of 10 people that filing names.
On the filing as: Director.
Edward Mathers is named as Director of Senti Biosciences Holdings, Inc. on the Form D that Senti Biosciences Holdings, Inc. filed with the SEC on 4 June 2026, one of 10 people that filing names.
On the filing as: Director.
Frances Schulz is named as Director of Senti Biosciences Holdings, Inc. on the Form D that Senti Biosciences Holdings, Inc. filed with the SEC on 4 June 2026, one of 10 people that filing names.
On the filing as: Director.
Donald Tang is named as Director of Senti Biosciences Holdings, Inc. on the Form D that Senti Biosciences Holdings, Inc. filed with the SEC on 4 June 2026, one of 10 people that filing names.
On the filing as: Director.
Brenda Cooperstone is named as Director of Senti Biosciences Holdings, Inc. on the Form D that Senti Biosciences Holdings, Inc. filed with the SEC on 4 June 2026, one of 10 people that filing names.
On the filing as: Director.
James Collins is named as Director of Senti Biosciences Holdings, Inc. on the Form D that Senti Biosciences Holdings, Inc. filed with the SEC on 4 June 2026, one of 10 people that filing names.
On the filing as: Director.
Feng Hsiung is named as Director of Senti Biosciences Holdings, Inc. on the Form D that Senti Biosciences Holdings, Inc. filed with the SEC on 4 June 2026, one of 10 people that filing names.
On the filing as: Director.
Bryan Baum is named as Director of Senti Biosciences Holdings, Inc. on the Form D that Senti Biosciences Holdings, Inc. filed with the SEC on 4 June 2026, one of 10 people that filing names.
On the filing as: Executive Officer.
Jay Cross is named as Chief Financial Officer of Senti Biosciences Holdings, Inc. on the Form D that Senti Biosciences Holdings, Inc. filed with the SEC on 4 June 2026, one of 10 people that filing names.
On the filing as: Executive Officer.
Kanya Rajangam is named as President, Head of Research and Development and Chief Medical Officer of Senti Biosciences Holdings, Inc. on the Form D that Senti Biosciences Holdings, Inc. filed with the SEC on 4 June 2026, one of 10 people that filing names.
10 people named on the filing — 3 holding an executive role and 7 as directors only.
Named as of the 2026-06-04 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Senti Biosciences Holdings, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Senti Biosciences Holdings, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Senti Biosciences Holdings, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Senti Biosciences Holdings, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Senti Biosciences Holdings, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-09-26 (investors.sentibio.com).
Each opens in a new tab, filled in for Senti Biosciences Holdings, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/senti-biosciences-holdings-inc-form-d-26000001